278 related articles for article (PubMed ID: 22968461)
1. How I treat HHV8/KSHV-related diseases in posttransplant patients.
Riva G; Luppi M; Barozzi P; Forghieri F; Potenza L
Blood; 2012 Nov; 120(20):4150-9. PubMed ID: 22968461
[TBL] [Abstract][Full Text] [Related]
2. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients.
Parravicini C; Olsen SJ; Capra M; Poli F; Sirchia G; Gao SJ; Berti E; Nocera A; Rossi E; Bestetti G; Pizzuto M; Galli M; Moroni M; Moore PS; Corbellino M
Blood; 1997 Oct; 90(7):2826-9. PubMed ID: 9326251
[TBL] [Abstract][Full Text] [Related]
3. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.
Du MQ; Bacon CM; Isaacson PG
J Clin Pathol; 2007 Dec; 60(12):1350-7. PubMed ID: 18042691
[TBL] [Abstract][Full Text] [Related]
4. HHV8-associated lymphoproliferative disorder in the peripheral blood.
Manogaran C; Kassam S
Blood; 2018 Jun; 131(25):2868. PubMed ID: 29930153
[No Abstract] [Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology.
Kemény L; Gyulai R; Kiss M; Nagy F; Dobozy A
J Am Acad Dermatol; 1997 Jul; 37(1):107-13. PubMed ID: 9216532
[TBL] [Abstract][Full Text] [Related]
6. Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) - review.
Iftode N; Rădulescu MA; Aramă ȘS; Aramă V
Rom J Intern Med; 2020 Dec; 58(4):199-208. PubMed ID: 32681788
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Yarchoan R
Curr Opin Oncol; 2012 Sep; 24(5):495-505. PubMed ID: 22729151
[TBL] [Abstract][Full Text] [Related]
8. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
9. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
10. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.
Du MQ; Liu H; Diss TC; Ye H; Hamoudi RA; Dupin N; Meignin V; Oksenhendler E; Boshoff C; Isaacson PG
Blood; 2001 Apr; 97(7):2130-6. PubMed ID: 11264181
[TBL] [Abstract][Full Text] [Related]
11. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma.
Hengge UR; Ruzicka T; Tyring SK; Stuschke M; Roggendorf M; Schwartz RA; Seeber S
Lancet Infect Dis; 2002 Jun; 2(6):344-52. PubMed ID: 12144897
[TBL] [Abstract][Full Text] [Related]
12. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection
Muniraju M; Mutsvunguma LZ; Reidel IG; Escalante GM; Cua S; Musonda W; Calero-Landa J; Farelo MA; Rodriguez E; Li Z; Ogembo JG
J Virol; 2024 Jun; 98(6):e0057624. PubMed ID: 38767375
[TBL] [Abstract][Full Text] [Related]
14. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
Kim B; Jeon YK; Kim CW
J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
[No Abstract] [Full Text] [Related]
16. Development of Kaposi sarcoma and hemophagocytic lymphohistiocytosis associated with human herpesvirus 8 in a renal transplant recipient.
Park YJ; Bae HJ; Chang JY; Yang CW; Chung BH
Korean J Intern Med; 2017 Jul; 32(4):750-752. PubMed ID: 26842102
[No Abstract] [Full Text] [Related]
17. New approaches to the treatment of human herpesvirus 8-associated disease.
Casper C
Rev Med Virol; 2008; 18(5):321-9. PubMed ID: 18615774
[TBL] [Abstract][Full Text] [Related]
18. [HHV-8 infection in renal transplantation].
Lebbé C
Nephrologie; 2001; 22(6):313-5. PubMed ID: 11715609
[No Abstract] [Full Text] [Related]
19. [Human herpesvirus 8 (HHV8). II. Pathogenic role and sensitivity to antiviral drugs].
Boulanger E
Ann Biol Clin (Paris); 1999; 57(1):19-28. PubMed ID: 9920963
[TBL] [Abstract][Full Text] [Related]
20. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
